Lupin's new facility will focus on the research and development of inhalation products for the treatment of asthma, allergic rhinitis etc
Lupin has announced the opening of its new Center of Excellence for Inhalation Research in Coral Springs, Florida. Local and state leaders, including Florida Lieutenant Governor Carlos Lopez-Cantera, Florida Department of Economic Opportunity Director Mr Jesse Panuccio, and Mayor Skip Campbell, were on site to celebrate the opening of Lupin's new facility with a ribbon cutting ceremony.
Lupin's new facility will focus on the research and development of inhalation products for the treatment of asthma, allergic rhinitis, chronic obstructive pulmonary diseases and other lung diseases.
"We are delighted to be making our mark in South Florida. With the talent and resources this state provides, our Coral Springs expansion will further strengthen our ability to bring quality, affordable pharmaceuticals to patients in the United States and other key markets globally. The new inhalation research and development facility is a significant step forward in our journey to emerge as a global specialty pharmaceutical player," said Ms Vinita Gupta, CEO, Lupin.
Lupin's Coral Springs facility was made possible through collaboration among Enterprise Florida, the Florida Department of Economic Opportunity, CareerSource Florida, Broward County and the Greater Fort Lauderdale Alliance.
"Lupin's grand opening in Broward County is an example of how our area is creating, attracting and expanding high-wage jobs. The company's South Florida presence strengthens our state's robust life sciences industry cluster and we wish them every success," said Mr Bob Swindell, president and CEO of the Greater Fort Lauderdale Alliance.
